Eleonora Allocati

Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

Brian Godman, Andrew Hill, Steven Simoens et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2021 · 73 citations · Full text

Pharmacy, Oncology, Pharmaceutical Policy +17

The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures

Evelien Moorkens, Brian Godman, Isabelle Huys et al. · Frontiers in Pharmacology · 2021 · 68 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacology +17

The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future

Brian Godman, Mainul Haque, Trudy Leong et al. · Frontiers in Public Health · 2021 · 37 citations · Full text

Medicine, Pharmacoeconomics, Pharmacology +13

Ongoing efforts to improve the management of patients with diabetes in Bangladesh and the implications

Mainul Haque, Salequl Islam, Zubair Mahmood Kamal et al. · Hospital Practice · 2021 · 25 citations · Full text

Pharmacy, Community Pharmacy, Pharmacy Practice +16

Surface plasmon resonance unveils important pitfalls of enzyme-linked immunoassay for the detection of anti-infliximab antibodies in patients’ sera

Marten Beeg, Cesare Burti, Eleonora Allocati et al. · Scientific Reports · 2021 · 25 citations · Full text

Life Sciences, Immunology, Internal Medicine +17